Formulation Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Cholestyramine 6.5% Ointment
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 306
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 307
|
Gabapentin 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 308
|
Ivermectin 0.8% Creme Rinse
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 309
|
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 310
|
Milk of Magnesia Concentrate, Unflavored
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 311
|
Natural Head Lice Repellant Spray
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 312
|
Niacinamide 4% Acne Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 313
|
Promethazine Hydrochloride 50 mg/mL in PLO Gel
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 314
|
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil
Allen Loyd V Jr
|
Jul/Aug 2024
Pg. 315
|
Amlodipine Besylate Veterinary Suspension
Allen Loyd V Jr
|
May/Jun 2024
Pg. 242
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 243
|
Diltiazem 5% in Lipoderm, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 244
|
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
May/Jun 2024
Pg. 245
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 130
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 131
|
Analgesic Compound Lotion, Clear
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 132
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 133
|
Diclofenac Sodium 1% Soft-patch Gel
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 134
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 135
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 136
|
Rectal Rockets: Lidocaine 3%, Hydrocortisone 2%
Allen Loyd V Jr
|
Mar/Apr 2024
Pg. 137
|
Differentiation and Treatment of Hypothyroidism, Functional Hypothyroidism, and Functional Metabolism
Paoletti Jim
|
Jan/Feb 2024
Pg. 34-43
|
Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 58
|
Estradiol 1-mg/0.1-g Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 59
|
Estriol and Estradiol 1.25, 2.5, and 5 mg (BiEst) Capsules
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 60
|
Progesterone 10% Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 61
|
Progesterone 100-mg/mL Sublingual Drops
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 62
|
Progesterone Vaginal Suppositories (Fatty Acid Base)
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 63
|
Testosterone 1 mg/0.1 mL in a PLO Gel
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 64
|
Triple Estrogen 2.5 mg Tablet Triturates
Allen Loyd V Jr
|
Jan/Feb 2024
Pg. 67
|
Compounded "Monster Spray" for Nighttime Terrors: A Case Report
Riepl Mike
|
Nov/Dec 2023
Pg. 446-448
|
Case Study: Personalized Oral Low-dose Naltrexone Titration for Pain Management
Rodriguez Franklin, Carvalho Maria, Banov Fabiana
|
Nov/Dec 2023
Pg. 468-473
|
Curcumin 1% Intranasal Mucoadhesive Gel
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 490
|
Hyaluronidase Injection
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 491
|
Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 492
|
Salicylic Acid 30% Gel
Allen Loyd V Jr
|
Nov/Dec 2023
Pg. 493
|
Compounding Metformin for Use in Functional Medicine
Desai Sarina, Thompson Tara
|
Sep/Oct 2023
Pg. 362-366
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike, Kaiser Joe
|
Sep/Oct 2023
Pg. 368-380
|
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 397-409
|
Crotamiton 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 412
|
Fluconazole 1% Thermoresponsive Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 414-415
|
Hydrocortisone 2% in Versapro Cream
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 416
|
Idoxuridine 5% in Dimethyl Sulfoxide
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 417
|
Ipratropium Bromide 0.05% Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 418-419
|
Nitazoxanide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 420
|
Povidone Iodine Lotion
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 421
|
Silver Sulfadiazine 1% and Hydrocortisone 2% Gel
Allen Loyd V Jr
|
Sep/Oct 2023
Pg. 422-423
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 4: The Legacy of Chronic COVID
Riepl Mike, Kaiser Joe
|
Jul/Aug 2023
Pg. 284-293
|
Chlorhexidine and Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 316
|
Clobazam 5-mg/mL Suspension
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 317-318
|
Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 319
|
Cyclosporine Topical Gel Formulation
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 320-321
|
Dexamethasone 1 mg/mL in Oral Mix SF
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 322
|
Lamotrigine 1 mg/mL in SuspendIt Plus
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 323
|
Levofloxacin 0.5% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 324-325
|
Losartan Potassium 2.5-mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 326
|
Nystatin Oromucosal Gel
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 327
|
Rifampin 10-mg/mL Nasal Drops
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 328
|
Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 329
|
Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt
Pramar Yahoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Jul/Aug 2023
Pg. 330-339
|
Warts: Pathophysiology, Types, Treatments, and Pharmaceutical Compounds
Touprong Robin, Thompson Tara, Williams LaVonn A
|
May/Jun 2023
Pg. 182-190
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 3: The Role of Toll-like Receptors in SARS-CoV-2 Infection and COVID Development
Riepl Mike, Kaiser Joe
|
May/Jun 2023
Pg. 192-200
|
Acetaminophen 500-mg/mL Rectal Solution
Allen Loyd V Jr
|
May/Jun 2023
Pg. 232-233
|
Doxycycline 166.7-mg/mL Oral Suspension (Veterinary)
Allen Loyd V Jr
|
May/Jun 2023
Pg. 234
|
Gentamicin 480-mg/1000-mL Bladder Irrigation
Allen Loyd V Jr
|
May/Jun 2023
Pg. 235
|
Methylene Blue 5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2023
Pg. 236
|
Migraine Headache Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 237
|
Nifedipine, Lidocaine, and Nitroglycerin Suppositories
Allen Loyd V Jr
|
May/Jun 2023
Pg. 238
|
Nystatin Oromucosal Viscous Suspension
Allen Loyd V Jr
|
May/Jun 2023
Pg. 239
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 2: Manifestations of Infection, Nomenclature, Transmission, and Treatment
Riepl Mike
|
Mar/Apr 2023
Pg. 98-107
|
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
|
Mar/Apr 2023
Pg. 108-112
|
Aminohippurate Sodium 250 mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 142
|
Amphotericin B 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 143
|
Aphthous Ulcer Gel
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 144
|
Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90%
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 145
|
Cyclosporine Topical Microemulsion
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 146
|
Hypochlorous Acid 0.01% Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 147
|
Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 148
|
Pilocarpine Hydrochloride 0.3% w/v Solution
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 149-151
|
Sacrosidase 8,500 Units Per mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 152
|
Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2023
Pg. 153
|
Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarum K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Mar/Apr 2023
Pg. 160-168
|
Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE
Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
|
Jan/Feb 2023
Pg. 6-10
|
Compounding for the Treatment of COVID-19 and Long COVID, Part 1: Terminology, Mutations, and Variants
Riepl Mike
|
Jan/Feb 2023
Pg. 12-21
|
Calculations
Stockton Shelly J
|
Jan/Feb 2023
Pg. 48-49
|
Acetaminophen 10 mg/mL for Rectal Use
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 50
|
Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 51
|
Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 52
|
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 53
|
Manning's Liniment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 54
|
Mayer's Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 55
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 56
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 57
|
Suspension Solution, Sugar Free
Allen Loyd V Jr
|
Jan/Feb 2023
Pg. 58-59
|
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
|
Nov/Dec 2022
Pg. 468-472
|
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Riepl Mike
|
Nov/Dec 2022
Pg. 480-488
|
Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 490-495
|
Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 508
|
Curcumin 2% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 509
|
Diazoxide 10-mg/mL in Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 510
|
Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 511
|
Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 512
|
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 513
|
Miller's Modified Mouthwash
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 514
|
Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding)
Allen Loyd V Jr
|
Nov/Dec 2022
Pg. 515
|
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
|
Nov/Dec 2022
Pg. 516-521
|
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera, Thompson Tara
|
Sep/Oct 2022
Pg. 378-384
|
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 400-408
|
Amphotericin B 3% Otic Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 422
|
Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 423
|
Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 424
|
Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 425
|
Clotrimazole 10-mg Troches
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 426
|
Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 427
|
Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 428
|
Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 429
|
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 430
|
Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
|
Sep/Oct 2022
Pg. 431
|
A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
|
Jul/Aug 2022
Pg. 270-274
|
Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 318
|
Cetrimide Lotion
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 319
|
Dexamethasone 1 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 320
|
Furosemide 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 321-322
|
Hydralazine Hydrochloride 10 mg/mL Oral Liquid
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 323-324
|
Indomethacin 1% Topical Gel
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 325-326
|
Nystatin 250,000-unit Frozen Popsicles
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 327
|
Povidone Iodine 100-mg/mL Solution/Spray
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 328
|
Psoriasis Topical Ointment
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 329
|
A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide
Riepl Mike
|
May/Jun 2022
Pg. 189-193
|
Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes
Allen Loyd V Jr
|
May/Jun 2022
Pg. 214-217
|
Alendronate Sodium 1% Topical Dental Gel
Allen Loyd V Jr
|
May/Jun 2022
Pg. 232
|
Azstarys in Ora-Blend Single Dose
Allen Loyd V Jr
|
May/Jun 2022
Pg. 233
|
Candesartan Cilexitil 1 mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2022
Pg. 234
|
Chloral Hydrate 70 mg/mL Syrup
Allen Loyd V Jr
|
May/Jun 2022
Pg. 235
|
Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle
Allen Loyd V Jr
|
May/Jun 2022
Pg. 236
|
Clobazam 1 mg/mL in Oral-Mix Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 237
|
Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion
Allen Loyd V Jr
|
May/Jun 2022
Pg. 238
|
Nitrazepam 1 mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2022
Pg. 239
|
Sirolimus 0.1% Ointment
Allen Loyd V Jr
|
May/Jun 2022
Pg. 240
|
Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
May/Jun 2022
Pg. 241
|
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
|
Mar/Apr 2022
Pg. 94-98
|
The Potential Effects of a Compounded Methylcobalamin Nasal Spray on Short-term Memory Loss After Intracranial Hemorrhage: A Case Report
Good Lauren, Lieu Yi, Banov Fabiana, Harger Beau, Banov Daniel
|
Mar/Apr 2022
Pg. 110-115
|
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 118-126
|
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 140
|
Codeine Phosphate 3 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 141
|
Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 142
|
Lorazepam 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 143
|
Mesalamine 100-mg/mL Suspension Enema
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 144
|
Naproxen 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 145
|
Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 146
|
Phenytoin 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 147
|
Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 148
|
Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2022
Pg. 149
|
Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report
Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
|
Jan/Feb 2022
Pg. 6-8
|
A Compendium of Compounding Agents and Formulations, Part 1: Melatonin
Riepl Mike
|
Jan/Feb 2022
Pg. 18-23
|
Sterile Basics: Compounding Sterile Preparations with Cyclodextrins
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 41-49
|
Aluminum Chloride 6.25% in Anhydrous Alcohol
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 52
|
Ascorbic Acid 10% in Anhydrous PEG ointment
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 53
|
Deoxyarbutin 3% Anhydrous Emulsion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 54
|
Diclofenac Sodium 1%-15% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 55
|
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 56
|
Mometasone Furoate 0.1% Lotion
Allen Loyd V Jr
|
Jan/Feb 2022
Pg. 57
|
Glycopyrrolate Sorbitol Lollipops for Drooling: Two Case Reports
Agbi Kelechi E, Carvalho Maria, Vieira-Banov Fabiana
|
Nov/Dec 2021
Pg. 464-467
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 4. Insulin
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Case Reports on the Use of Aloe Vera, Naltrexone, and Topiramate for the Treatment of Scars
Harris Kylie, Wright Edward
|
Nov/Dec 2021
Pg. 482-485
|
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents)
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 486-489
|
Domperidone 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 500
|
Kayexalate in Lactulose
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 501
|
Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 502
|
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 503
|
Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 504
|
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 505
|
Quetiapine Fumarate 10 mg/mL in Ora-Blend
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 506
|
Shari's Burn Cream
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 507
|
Sulfadiazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 508
|
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 509
|
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
|
Nov/Dec 2021
Pg. 523-527
|
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 412
|
Cilazapril 1-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 413
|
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 414
|
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 415
|
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 416
|
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 417
|
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 418
|
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 419
|
Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 420
|
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 421
|
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Sep/Oct 2021
Pg. 431-439
|
Growing a Compounding Practice: Successful Marketing to Underserved Populations
McKettrick Greg, Yoch Doug
|
Jul/Aug 2021
Pg. 270-274
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Riepl Mike
|
Jul/Aug 2021
Pg. 282-287
|
Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 320
|
Atomoxetine 4-mg/mL Oral Solution/Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 321
|
BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel)
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 322
|
Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 323
|
Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 324
|
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Moh's Paste, Modified
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 326
|
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 327
|
Tacrolimus 0.1% Topical Microemulsion
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 328
|
Valsartan 4-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 329
|
A Simplified Method for Compounding Lidocaine Topical Gel: A Demonstration of Quality Assurance to Prevent Errors in 503A Pharmacies
Hall Essence, Levesque Dan, Rashid Mamoon, Mullins Randy, Hossain Mohammad Faisal
|
May/Jun 2021
Pg. 197-204
|
Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 232
|
Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 233
|
Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 234
|
Temozolomide 10 mg/mL in Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2021
Pg. 235
|
The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report
McKettrick Greg, Yoch Doug
|
Mar/Apr 2021
Pg. 94-98
|
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing
Riepl Mike
|
Mar/Apr 2021
Pg. 100-103
|
Amlodipine 1-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 142
|
Canine Soft Chew Base (Veterinary)
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 143
|
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 144
|
Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2021
Pg. 145
|
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 31-38
|
Calculations
Stockton Shelly J
|
Jan/Feb 2021
Pg. 40
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 45
|
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 46
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Design and Performance of an Inexpensive Water Activity Meter
Gilda Sagar S, Schober Joseph M, McPherson Timothy
|
Jan/Feb 2021
Pg. 48-51
|
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration
Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
|
Jan/Feb 2021
Pg. 52-61
|
Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew, Zhao Fang, Dave Vivek S
|
Jan/Feb 2021
Pg. 82-87
|
Cocamidopropyl Betaine Surfactant 0.075% Solution in Physiological Serum for Hygiene Process of COVID-19 Intubated Patients
Nogales Luis Marcos, Jiménez Labaig Luis, Abarca Lachén Edgar, Gil Melcón María, López-Nieves Marisol
|
Sep/Oct 2020
Pg. 358-364
|
Topical Cholesterol/Simvastatin Gel for the Treatment of CHILD Syndrome in an Adolescent
Cho Sung Kyung, Ashworth Lisa Diggs, Goldman Shauna
|
Sep/Oct 2020
Pg. 367-369
|
Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection
(Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection
(Vet-Mouse)
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 406
|
Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2020
Pg. 407
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
Benzonatate 50 mg/mL in Ora-Sweet
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 312
|
Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 313
|
Doxepin Hydrochloride 5% in Cetaphil Cream
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 314
|
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 315
|
Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 316
|
Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 317
|
Lisinopril 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 318
|
Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 319
|
Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream)
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 320
|
Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jul/Aug 2020
Pg. 321
|
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 182-186
|
Compounding Pearls -- Wound Care: Burn Healing, Part 1
Riepl Mike
|
May/Jun 2020
Pg. 188-193
|
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Hagan John C III, Everett Eric, Chamberlain Tyler
|
May/Jun 2020
Pg. 194-197
|
Baclofen 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 224
|
Dexamethasone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 225
|
Diphenylcyclopropenone 0.1% or 3% in Isopropranol
Allen Loyd V Jr
|
May/Jun 2020
Pg. 226
|
Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2020
Pg. 227
|
Monsel's Solution, Gel, and Paste
Allen Loyd V Jr
|
May/Jun 2020
Pg. 228
|
Prednisolone 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 229
|
Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 230
|
Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2020
Pg. 231
|
Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary
Allen Loyd V Jr
|
May/Jun 2020
Pg. 232
|
Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension
Allen Loyd V Jr
|
May/Jun 2020
Pg. 233
|
Compounding Pearls -- Wound Care: Base Selection
Riepl Mike
|
Mar/Apr 2020
Pg. 98-102
|
Low-dose Pilocarpine Spray to Treat Xerostomia
Zur Eyal
|
Mar/Apr 2020
Pg. 104-108
|
Acetazolamide 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 130
|
Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 131
|
Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 132
|
Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 133
|
Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 134
|
Propylthiouracil 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 135
|
Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 136
|
Terbinafine 25 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 137
|
Topiramate 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 138
|
Valsartan 4 mg/mL in Syrup NF
Allen Loyd V Jr
|
Mar/Apr 2020
Pg. 139
|
Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 54
|
Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 55
|
Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 56
|
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 57
|
Isoniazid 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 58
|
LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 59
|
Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 60
|
Potassium Chloride 1 mmol/mL in Ora-Sweet SF
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 61
|
Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 62
|
Venlafaxine 15 mg/mL in Syrup
Allen Loyd V Jr
|
Jan/Feb 2020
Pg. 63
|
Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution
Marotta James C, Patel Gopesh, Carvalho Maria, Blakeney Samantha
|
Jan/Feb 2020
Pg. 69-76
|
Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 486
|
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 487
|
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 488
|
Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 489
|
Sulfasalazine 100 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 490
|
Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 491
|
Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 492
|
Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 493
|
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 494
|
Zonisamide 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Nov/Dec 2019
Pg. 495
|
Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report
Pope George, Daleo Charles, Batson SL
|
Sep/Oct 2019
Pg. 358-364
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
|
Sep/Oct 2019
Pg. 366-375
|
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
|
Sep/Oct 2019
Pg. 376-381
|
Allopurinol 20 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 406
|
Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 407
|
Dipyridamole 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 408
|
Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 409
|
Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 410
|
Sorafenib Capsules for Pediatric Use
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 411
|
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 412
|
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1)
Allen Loyd V Jr
|
Sep/Oct 2019
Pg. 413
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Zur Eyal
|
Jul/Aug 2019
Pg. 288-293
|
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 314
|
Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 315
|
Domperidone 5 mg/mL in Oral Mix
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 316
|
Lorazepam 1 mg/mL in Anhydrous Organic Solvent System
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 317
|
Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 318
|
Rifampin 25 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2019
Pg. 319
|
Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
Riepl Mike
|
May/Jun 2019
Pg. 192-199
|
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Zur Eyal
|
May/Jun 2019
Pg. 200-207
|
Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
Allen Loyd V Jr
|
May/Jun 2019
Pg. 230
|
Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 231
|
Clopidogrel 5 mg/mL in a Sugar-Free Syrup
Allen Loyd V Jr
|
May/Jun 2019
Pg. 232
|
Flunisolide Nasal Spray
Allen Loyd V Jr
|
May/Jun 2019
Pg. 233
|
Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2019
Pg. 234
|
Methotrexate 2-mg/mL Oral Solution
Allen Loyd V Jr
|
May/Jun 2019
Pg. 235
|
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
Allen Loyd V Jr
|
May/Jun 2019
Pg. 236
|
Valsartan 16-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2019
Pg. 237
|
Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
Rashid Mamoon, Hossain Mohammad Faisal, Nounou Mohamed, Rahman Mehbuba, Sarkar Sushanta, Adeyemo Akinola, Mullins Randy
|
May/Jun 2019
Pg. 250-257
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Zur Eyal
|
Mar/Apr 2019
Pg. 94-104
|
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
|
Mar/Apr 2019
Pg. 106-111
|
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia
Zur Eyal
|
Mar/Apr 2019
Pg. 113-119
|
Acetaminophen 50% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 146
|
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 147
|
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 148
|
Dexamethasone 2 mg/g Topical Paste, Veterinary
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 149
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 150
|
Perphenazine 0.5 mg/mL Oral Liquid
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 151
|
Rosuvastatin 20-mg/5-mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 152
|
Tacrolimus 0.5 mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Mar/Apr 2019
Pg. 153
|
Physicochemical Stability of Extemporaneously Prepared Methylcobalamin Injections in the Presence and Absence of Preservative and the Impact of Light Exposure
Ip Kendice, Banov Daniel, Bassani Gus, Morgan Latisha
|
Mar/Apr 2019
Pg. 167-175
|
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Williams LaVonn A
|
Jan/Feb 2019
Pg. 14-21
|
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Zur Eyal
|
Jan/Feb 2019
Pg. 23-31
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 52
|
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 53
|
Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 54
|
Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 55
|
Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 56
|
Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 57
|
Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 58
|
Orodispersible Film
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 59
|
Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 60
|
Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2019
Pg. 61
|
Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle
Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
|
Jan/Feb 2019
Pg. 65-69
|
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
|
Jan/Feb 2019
Pg. 70-76
|
Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
|
Jan/Feb 2019
Pg. 77-81
|
Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications
Zur Eyal
|
Nov/Dec 2018
Pg. 446-454
|
Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
|
Nov/Dec 2018
Pg. 456-465
|
Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 492
|
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 493
|
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 494
|
Hydrocortisone 2 mg/mL in Inorpha Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 495
|
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 496
|
Prednisone 5 mg/mL ir Oral Mix Suspension
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 497
|
Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin
Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
|
Nov/Dec 2018
Pg. 498-503
|
Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase)
Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
|
Nov/Dec 2018
Pg. 504-511
|
PreScription: Updating Formulations
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 356
|
Cysteamine 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 408
|
Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 409
|
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 410
|
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension
Allen Loyd V Jr
|
Sep/Oct 2018
Pg. 411
|
Stability of Tranexamic Acid Mouth Rinse
Donnelly Ronald F
|
Sep/Oct 2018
Pg. 412-416
|
Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding
Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
|
Sep/Oct 2018
Pg. 433-439
|
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
Muller George, Grieshaber Robert, Talley J Floyd, Riepl Mike, Fellows Don
|
Jul/Aug 2018
Pg. 270-278
|
Anhydrous Medium-chain Triglycerides Gel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 316
|
Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 317
|
Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 318
|
Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 319
|
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 320
|
Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 321
|
Minoxidil 50 mg/mL in Espumil Foam Base
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 322
|
Oseltamivir Phosphate 15 mg/mL in SyrSpend SF
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 323
|
Pentoxifylline 5% in Dermabase
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 324
|
Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2018
Pg. 325
|
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension
Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J
|
Jul/Aug 2018
Pg. 326-328
|
Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes
Huffman Jessica, Brown Stacy, Lewis Paul, Lawson Sarah, Ogle Amanda, Peacock Gina
|
Jul/Aug 2018
Pg. 340-344
|
Pitch Ointment: Applications in Scar and Wound Management
Kloesel Lawson, Carvalho Maria, Banov Fabiana
|
May/Jun 2018
Pg. 182-188
|
Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications
Agbi Kelechi E, Hover Sara, Carvalho Maria
|
May/Jun 2018
Pg. 196-202
|
Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
|
May/Jun 2018
Pg. 232
|
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
May/Jun 2018
Pg. 233
|
Dorzolamide 2% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2018
Pg. 234
|
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 235
|
Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 236
|
Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture
Allen Loyd V Jr
|
May/Jun 2018
Pg. 237
|
Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 238
|
Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 239
|
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O, Zdoryk Oleksandr A
|
May/Jun 2018
Pg. 240-246
|
Erratum: Formulation: Lansoprazole 3-mg/mL Oral Suspension
|
May/Jun 2018
Pg. 263
|
Basics of Compounding: Compounding Microemulsions
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 137-143
|
Clonidine Hydrochloride 10 mg/mL in Inorpha Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 146
|
Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 147
|
Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 148
|
Levodopa and Carbidopa Rectal Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 149
|
Prochlorperazine Edisylate 0.5% Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 150
|
Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 151
|
Spironolactone 5-mg/mL in Suspendit Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 152
|
Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet)
Allen Loyd V Jr
|
Mar/Apr 2018
Pg. 153
|
Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients
McElhiney Linda F
|
Jan/Feb 2018
Pg. 30-39
|
Glutamate and Aspartate Cardioplegia Additive Solution
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 50
|
Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 51
|
Metronidazole 50 mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 52
|
Miconazole 10% in Recura Topical Cream
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 53
|
Naproxen 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 54
|
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 55
|
Ranitidine 15 mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 56
|
Sodium Citrate 9% Nasal Spray for Olfactory Disorders
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 57
|
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 58
|
Voriconazole 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2018
Pg. 59
|
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018
Pg. 66-75
|
Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 481-486
|
Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 490
|
Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 491
|
Fluconazole 10% in RECURA Cream
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 492
|
Haloperidol 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 493
|
Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 494
|
Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 495
|
Spironolactone 5 mg/mL in SuspendIt Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 496
|
Tolmetin 400-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 497
|
Trace Elements Injection 5
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 498
|
Vancomycin 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2017
Pg. 499
|
Validation of the Technological Process of the Preparation "Milk by Vidal"
Savchenko LP, Mishchenko VA, Georgiyants VA
|
Nov/Dec 2017
Pg. 513-517
|
Acetylcysteine Solutions for Inhalation
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 408
|
Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 409
|
Etoposide 20-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 410
|
Fentanyl Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 411
|
Fluoxymesterone 10-mg Capsules
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 412
|
Ioversol Injection
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 413
|
Levocarnitine 100-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 414
|
Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 415
|
Tacrolimus 0.3-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 416
|
Vancomycin 50 mg/mL in Oral Syrup Suspension
Allen Loyd V Jr
|
Sep/Oct 2017
Pg. 417
|
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas
Choo Winnie
|
Jul/Aug 2017
Pg. 282-289
|
Calculations
Stockton Shelly J
|
Jul/Aug 2017
Pg. 310
|
Betamethasone 0.1% and Neomycin 0.6% Gel-Cream
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 312
|
Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 313
|
Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 314
|
Disopyramide 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 315
|
Ferrous Sulfate 30-mg Fe/mL Oral Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 316
|
Reteplase Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 317
|
Sertraline Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 318
|
Tacrolimus 0.06% Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 319
|
Torsemide 10-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 320
|
Tranilast 8% Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
Jul/Aug 2017
Pg. 321
|
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017
Pg. 322-329
|
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Jones Nat, Carvalho Maria, Branvold-Herr Andrea
|
May/Jun 2017
Pg. 205-211
|
Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 232
|
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 233
|
Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base
Allen Loyd V Jr
|
May/Jun 2017
Pg. 234
|
Meloxicam 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2017
Pg. 235
|
Ofloxacin 0.3% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2017
Pg. 236
|
PVP Iodine 10% Antiseptic Cream
Allen Loyd V Jr
|
May/Jun 2017
Pg. 237
|
Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases
Allen Loyd V Jr
|
May/Jun 2017
Pg. 238
|
Trimethoprim 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2017
Pg. 239
|
Azathioprine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 146
|
Candesartan Cilexetil 8 mg Liquid-Filled Capsules
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 147
|
Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 148
|
Ketoconazole 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 149
|
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
|
Jan/Feb 2017
Pg. 22-27
|
Basics of Compounding with Dilutions and Concentrates
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 39-45
|
Clindamycin 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 60
|
Diazoxide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 61
|
Infliximab 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 62
|
Nifedipine 0.5% Rectal Ointment
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 63
|
Tetracaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 64
|
Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2017
Pg. 65
|
A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding
Rush Steven D, Vernak Charlene, Zhao Fang
|
Jan/Feb 2017
Pg. 83-87
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 495-500
|
Calculations
Stockton Shelly J
|
Nov/Dec 2016
Pg. 502
|
Alendronate 70-mg/75-mL Drinkable Formulation
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 504
|
Bosentan 6.25-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 505
|
Capsaicin 0.025% and Doxepin 3.3% Cream
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 506
|
Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 507
|
Erlotinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 508
|
Flumazenil 0.1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 509
|
Imatinib 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 510
|
Lapatinib Ditosylate 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 511
|
Melatonin 2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 512
|
Menthol, Chloral Hydrate, and Camphor Analgesic Ointment
Allen Loyd V Jr
|
Nov/Dec 2016
Pg. 513
|
Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 399-404
|
Clobazam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 406
|
Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 407
|
Inamrinone 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 408
|
Levetiracetam 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 409
|
Naproxen 5% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 410
|
Permethrin 1% Lotion
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 411
|
Progesterone 10% Cream
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 412
|
Sodium Phosphate Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 413
|
Tetracaine Hydrochloride 2% Topical Solution
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 414
|
Tromethamine Injection
Allen Loyd V Jr
|
Sep/Oct 2016
Pg. 415
|
Basics of Compounding: Compounding Films
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 298-305
|
Dolasetron Mesylate 20-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 318
|
Gatifloxacin 0.5% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 319
|
Mebendazole 100-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 320
|
Neomycin Sulfate 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 321
|
Nystatin 100,000-units Vaginal Inserts
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 322
|
1,2-Octanediol 5% Topical Liquid
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 323
|
Phytonadione 1-mg/mL Oral Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 324
|
Plasmingen and Hyaluronate Sodium Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 325
|
Scopolamine Hydrobromide 0.25% Ophthalmic Solution
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 326
|
Tretinoin 10-mg Oral Capsules
Allen Loyd V Jr
|
Jul/Aug 2016
Pg. 327
|
Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
Sturn Kayla M, Collin Michael
|
May/Jun 2016
Pg. 197-201
|
Basics of Compounding: Special Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 209-214
|
Calculations
Stockton Shelly J
|
May/Jun 2016
Pg. 224
|
Carboplatin 50-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 226
|
Cefotetan Disodium Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 227
|
Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment
Allen Loyd V Jr
|
May/Jun 2016
Pg. 228
|
Dexpanthenol 5% Nasal Spray
Allen Loyd V Jr
|
May/Jun 2016
Pg. 229
|
Indomethacin Gel
Allen Loyd V Jr
|
May/Jun 2016
Pg. 230
|
Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm
Allen Loyd V Jr
|
May/Jun 2016
Pg. 231
|
Montelukast Sodium 5-mg Fast-Dissolving Film
Allen Loyd V Jr
|
May/Jun 2016
Pg. 232
|
Pain-Away II Headache Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 233
|
Sodium Nitroprusside 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2016
Pg. 234
|
Zolpidem Tartrate 5-mg and 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2016
Pg. 235
|
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children
Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
|
May/Jun 2016
Pg. 257-261
|
Basics of Compounding: Capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 125-134
|
Blue Goo Anti-Itch Gel
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 144
|
Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 145
|
Medicated Polyox Bandage for Skin Ulcers
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 146
|
Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray
Allen Loyd V Jr
|
Mar/Apr 2016
Pg. 147
|
Calculations
Stockton Shelly J
|
Jan/Feb 2016
Pg. 46
|
Aprepitant 80-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 48
|
Aripiprazole 10-mg Oral Dissolving Tablets
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 49
|
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 50
|
Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 51
|
Mupirocin Calcium 2% Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 52
|
Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 53
|
Thrombin 1,000 Units/mL Topical Solution, Sterile
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 54
|
Tropicamide 1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 55
|
Vancomycin 5% and Amikacin 2% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 56
|
Voriconazole 10-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2016
Pg. 57
|
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 504
|
Cefepime Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 505
|
Cefotaxime 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 506
|
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 507
|
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 508
|
Estradiol Valerate 40-mg/mL in Oil Injection
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 509
|
Levetiracetam 100-mg/mL Injection (Concentrate)
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 510
|
Memantine Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 511
|
Mupirocin 2% Nasal Ointment
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 512
|
Propranolol Hydrochloride Capsules
Allen Loyd V Jr
|
Nov/Dec 2015
Pg. 513
|
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries
Guth Michael AS
|
Sep/Oct 2015
Pg. 367-373
|
Aminocaproic Acid 250-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 404
|
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 405
|
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 406
|
Nimodipine 3-mg/mL Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 407
|
Ofloxacin 0.3% Otic Solution
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 408
|
Povidone Iodine 10% Cold Sore Paint
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 409
|
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 410
|
Vehicle for Oral Solution (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 411
|
Vehicle for Oral Solution, Sugar Free (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 412
|
Vehicle for Oral Suspension (National Formulary 26)
Allen Loyd V Jr
|
Sep/Oct 2015
Pg. 413
|
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
|
Sep/Oct 2015
Pg. 414-419
|
Ammonium Molybdate 25-mcg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 324
|
Balsam Peru, Castor Oil, and Trypsin Ointment
Allen Loyd V
|
Jul/Aug 2015
Pg. 325
|
Benzonatate 100-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 326
|
Chloroquine Phosphate 250-mg Capsules
Allen Loyd V
|
Jul/Aug 2015
Pg. 327
|
Cytarabine 50-mg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 328
|
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 329
|
Oxytocin 10-units/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 330
|
Phytonadione 2-mg/mL Injection
Allen Loyd V
|
Jul/Aug 2015
Pg. 331
|
Proparacaine Hydrochloride 0.5% Ophthalmic Solution
Allen Loyd V
|
Jul/Aug 2015
Pg. 332
|
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg
Allen Loyd V
|
Jul/Aug 2015
Pg. 333
|
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy
Guth Michael AS
|
May/Jun 2015
Pg. 195-203
|
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls
Gonzalez Mark
|
May/Jun 2015
Pg. 205-211
|
Atropine Sulfate 1% Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 242
|
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
|
May/Jun 2015
Pg. 243
|
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches
Allen Loyd V Jr
|
May/Jun 2015
Pg. 244
|
Phenazopyridine Hydrochloride 200-mg Capsules
Allen Loyd V Jr
|
May/Jun 2015
Pg. 245
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 246
|
Scopolamine Hydrobromide -.4-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2015
Pg. 247
|
Protocol of Blood Serum Eye Drops
Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos
|
May/Jun 2015
Pg. 252-260
|
Acne Scrub
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 142
|
Aminohippurate Sodium 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 143
|
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 144
|
Heparin 335-United/Gram Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 145
|
L-Cysteine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 146
|
Morrhuate Sodium 5% Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 147
|
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 148
|
Pancuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 149
|
Physostigmine Salicylate 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 150
|
Trypan Blue 0.06% Ophthalmic Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 151
|
Atenolol 25-, 50-, or 100-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 60
|
Azathioprine 50-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 61
|
Cisplatin 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 62
|
Daunorubicin 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 63
|
Erythromycin 50-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 64
|
Hydralazine Hydrochloride 20-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 65
|
Hydroxychloroquine Sulfate 200-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 66
|
Lidocaine Hydrochloride 4% Topical Solution
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 67
|
Mupirocin 2% Ointment
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 68
|
Phentolamine Mesylate 5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2015
Pg. 69
|
PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 444
|
Clarithromycin 250-mg or 500-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 494
|
Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 495
|
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 496
|
Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 497
|
Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 498
|
Methazolamide 25-mg or 50-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 499
|
Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 500
|
Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 501
|
Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 502
|
Tamsulosin Hydrochloride 0.2-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 503
|
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
|
Sep/Oct 2014
Pg. 370-377
|
Health Care in Belarus in the 19th and 20th Centuries
Tishchenko Evgenii Mikhailovich
|
Sep/Oct 2014
Pg. 382-391
|
Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 408
|
Bacitracin Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 409
|
Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 410
|
Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 411
|
Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 412
|
Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 413
|
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 414
|
Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 415
|
Sumatriptan Succinate 12-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 416
|
Tranexamic Acid 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 417
|
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Barium Sulfate Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 323
|
Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 324
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Chlorothiazide 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 326
|
Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 327
|
Denileukin Diftitox 150-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 328
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 330
|
Zinc 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 331
|
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith, Tuder Dmitry
|
May/Jun 2014
Pg. 182-188
|
Atorvastatin 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 232
|
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 233
|
Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 234
|
Butorphanol Tartrate 10-mg/mL Nasal Spray
Allen Loyd V Jr
|
May/Jun 2014
Pg. 235
|
Dibucaine 1% Ointment
Allen Loyd V Jr
|
May/Jun 2014
Pg. 236
|
Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 237
|
Methotrexate 2.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 238
|
Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2014
Pg. 239
|
Tamoxifen 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 240
|
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 241
|
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms
Sandle Tim
|
May/Jun 2014
Pg. 242-247
|
Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
|
May/Jun 2014
Pg. 248-252
|
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014
Pg. 253-255
|
Compounding Practices in Iran
Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
|
Mar/Apr 2014
Pg. 112-116
|
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 131-134
|
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 142
|
Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 143
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 145
|
Polymixin B Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 146
|
Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 147
|
Secretin 4 mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 148
|
Selenium 40-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 149
|
Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 150
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
|
Mar/Apr 2014
Pg. 169-174
|
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
|
Jan/Feb 2014
Pg. 14-19
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 61
|
Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 62
|
Lomustine 100-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 63
|
Neostigmine Bromide 15-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 64
|
Nimodipine 30-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 65
|
Phenobarbital 60-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 66
|
Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 67
|
Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 68
|
Vasopressin 20-units/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 69
|
Basics of Compounding: Basics of Compounding with Balsams
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 490-495
|
Benztropine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 498
|
Cefazolin 250-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 499
|
Ciprofloxacin 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 500
|
Cortisone Acetate 25-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 501
|
Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 502
|
Dihydroergotamine Mesylate 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 503
|
Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate)
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 504
|
Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 505
|
Metyrosine 250-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 506
|
Phenytoin Sodium 50-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2013
Pg. 507
|
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
|
Sep/Oct 2013
Pg. 364-368
|
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
|
Sep/Oct 2013
Pg. 380-383
|
Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines
Pruitt Bobby N III
|
Sep/Oct 2013
Pg. 384-387
|
Basics of Compounding: Basics of Compounding with Tars
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 400-410
|
Acyclovir 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 414
|
Aminocaproic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 415
|
Clindamycin 150-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 416
|
Fluorouracil 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 417
|
Hydroxyzine Hydrochloride 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 418
|
Indomethacin 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 419
|
Mesna 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 420
|
Methotrexate 25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 421
|
Phenylephrine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 422
|
Terbutaline Sulfate 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2013
Pg. 423
|
Jet Injection Devices for the Needle-free Administration of Compounds, Vaccines, and Other Agents
Logomasini Mark A, Stout Richard R, Ron Marcinkoski
|
Jul/Aug 2013
Pg. 270-280
|
Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 312-322
|
Acyclovir 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 326
|
Acyclovir 200-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 327
|
Allopurinol Sodium 4-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 328
|
Amikacin Sulfate 250-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 329
|
Dacarbazine 200-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 330
|
Ketamine 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 331
|
Methohexital Sodium 500-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 332
|
Metoprolol Tartrate 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 333
|
Rifampin 300-mg and Isoniazid 150-mg Capsules
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 334
|
Succinylcholine Chloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2013
Pg. 335
|
Buffered Aspirin Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 228
|
Calcium Acetate 667-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 229
|
Estradiol 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 230
|
Ethambutol 400-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 231
|
Isoniazid 300-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 232
|
Labetalol 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 233
|
Mercaptopurine 75-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 234
|
Naltrexone Hydrochloride 50-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 235
|
Prednisone 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 236
|
Reserpine 0.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2013
Pg. 237
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Adenosine 3-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 144
|
Alcohol Dehydrated Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 145
|
Betahistine 16-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 146
|
Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 147
|
Cyanocobalamin 1000-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 148
|
Dexrazoxane 1-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 149
|
Meropenem 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 150
|
Paclitaxel 6-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 151
|
Thiotepa 15-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 152
|
Verapamil Hydrochloride 2.5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 153
|
Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Wung Deanna
|
Jan/Feb 2013
Pg. 24-27
|
Adrenal Fatigue
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 39-44
|
Desmopressin 4-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 64
|
Dobutamine 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 65
|
Granisetron 1-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 66
|
Ibuprofen 10-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 67
|
Mepivacaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 68
|
Milrinone 0.2-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 69
|
Neostigmine Methylsulfate 0.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 70
|
Nicardipine Hydrochloride Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 71
|
Octreotide 50-mcg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 72
|
Testosterone Cypionate 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 73
|
Errata
Allen Loyd V Jr
|
Jan/Feb 2013
Pg. 86
|
Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
|
Nov/Dec 2012
Pg. 462-469
|
Aminophylline 25-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 500
|
Ammonium Chloride 5-mEq/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 501
|
Azathioprine 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 502
|
Copper 0.4-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 503
|
Dipyridamole 5-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 504
|
Dopamine Hydrochloride 80-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 505
|
Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 506
|
Papaverine Hydrochloride 30-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 507
|
Valproate Sodium 100-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 508
|
Vercuronium Bromide 1-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2012
Pg. 509
|
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
McNulty Jack P, Hahn Kristian
|
Sep/Oct 2012
Pg. 364-368
|
Bioidentical Thyroid Replacement Therapy in Practice: Delivering a Physiologic T4-T3 Ratio for Improved Patient Outcomes with the Listecki-Snyder Protocol
Snyder Scott, Listecki Robert E
|
Sep/Oct 2012
Pg. 376-380
|
Metronidazole 5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 425
|
Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies
Zur Eyal
|
Sep/Oct 2012
Pg. 386-393
|
Doxapram Hydrochloride 20-mg/mL injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 418
|
Enalaprilat 1.25-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 419
|
Esmolol Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 420
|
Fluconazole 2-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 421
|
Haloperidol 50-mg/mL in Oil Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 422
|
Meperidine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 423
|
Methocarbamol 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 424
|
Nalbuphine Hydrochloride 10-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 426
|
Oxymorphone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2012
Pg. 427
|
Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date
Peacock Gina F, Sauvageot Jurgita
|
Sep/Oct 2012
Pg. 428-430
|
A Concise Discussion of Headache Types, Part 3: Migraine
Williams LaVonn A, Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 270-274
|
Compounding Prokinetic Medications for Companion Animals
Gaskins Jessica
|
Jul/Aug 2012
Pg. 276-286
|
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Zur Eyal
|
Jul/Aug 2012
Pg. 288-293
|
Betamethasone 0.6-mg/5-mL Syrup
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 332
|
Butorphanol Tartrate 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 333
|
Diphenhydramine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 334
|
Etomidate 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 335
|
Foscarnet Sodium 24-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 336
|
Ketorolac Tromethamine 15-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 337
|
Methyldopate Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 338
|
Ondansetron Hydrochloride 2-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 339
|
Sufentanil Citrate 50-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 340
|
Tobramycin 40-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2012
Pg. 341
|
Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets
Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'
|
Jul/Aug 2012
Pg. 342-346
|
I See Colors: Using Vital Dyes in Diagnosing Ophthalmic Disease
McElhiney Linda F
|
May/Jun 2012
Pg. 190-195
|
Burning Mouth Syndrome: A Discussion of a Complex Pathology
Zur Eyal
|
May/Jun 2012
Pg. 196-205
|
Treatment and Prevention of Insect Bites: Mosquitoes
Williams LaVonn A, Allen Loyd V Jr
|
May/Jun 2012
Pg. 210-218
|
Acetazolamide 100-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 238
|
Alfentanil 500-mcg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 239
|
Ascorbic Acid 250-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 240
|
Diltiazem Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 241
|
Famotidine 10-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 242
|
Metoclopramide 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 243
|
Naloxone Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 244
|
Orphenadrine Citrate 30-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 245
|
Prochlorperazine 5-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 246
|
Ranitidine 25-mg/mL Injection
Allen Loyd V Jr
|
May/Jun 2012
Pg. 247
|
Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris, Delano Amy
|
Mar/Apr 2012
Pg. 110-114
|
Midazolam 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 162
|
Promethazine Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 163
|
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Zur Eyal
|
Mar/Apr 2012
Pg. 117-124
|
A Concise Discussion of Headache Types, Part 1
Williams LaVonn A
|
Mar/Apr 2012
Pg. 125-132
|
Amiodarone Hydrochloride 50-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 154
|
Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 155
|
Caffeine Citrate 20-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 156
|
Chromium 4-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 157
|
Furosemide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 158
|
Glycopyrrolate 0.2-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 159
|
Labetalol Hydrochloride 5-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 160
|
Lorazepam 4-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 161
|
Sodium Chloride 14.6% and 23.4% Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 77
|
Sodium Phosphates Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 78
|
Zinc 1-mg/mL and 5-mg/mL Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 79
|
Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
McElhiney Linda F
|
Jan/Feb 2012
Pg. 12-16
|
Vitamins: Therapy or Hype
Wynn Tom, Hoffrogge Zach
|
Jan/Feb 2012
Pg. 17-21
|
Oral Mucositis: Etiology and Clinical and Pharmaceutical Management
Zur Eyal
|
Jan/Feb 2012
Pg. 22-33
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 75
|
Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 76
|
Case Studies of Compounded Tramadol Use in Cats
Ray Joel, Jordan Dinah, Pinelli Chris, Fackler Bethany, Boggess Donan, Clark Justin
|
Jan/Feb 2012
Pg. 44-49
|
Calculations
Stockton Shelly J
|
Jan/Feb 2012
Pg. 69
|
Calcium Chloride 10% Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 70
|
Calcium Gluconate 10% Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 71
|
Magnesium Sulfate 10% Injection (0.8 mEq/mL)
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 72
|
Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 73
|
Potassium Phosphates Injection
Allen Loyd V Jr
|
Jan/Feb 2012
Pg. 74
|
Compounding for Treatment of Equine Infectious Diseases: An Overview
Bramwell Bethany L
|
Nov/Dec 2011
Pg. 450-457
|
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Zur Eyal
|
Nov/Dec 2011
Pg. 458-463
|
Diaper Rash Relief: Common Sense Remedies and Treatments
Wiliams Kacee D, Williams LaVonn
|
Nov/Dec 2011
Pg. 464-469
|
Cefepime 1% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 500
|
Citric Acid 3% Mouthrinse Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 501
|
Dapsone 5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 502
|
Lavender Oil 4% in Polyethylene Glycol Ointment
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 503
|
Oxandrolone 2-mg/mL Oral Liquid
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 505
|
Thioguanine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 506
|
Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 507
|
Vancomycin 31-mg/mL Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 508
|
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 504
|
Vancomycin 2% in Silver Sulfadiazine Cream
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 509
|
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride
Zur Eyal
|
Sep/Oct 2011
Pg. 358-366
|
Carvedilol 0.625-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 418
|
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 419
|
Lorazepam 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 420
|
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 421
|
Nifedipine 1-mg/500-mg Oral Powder
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 422
|
Nifedipine 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 423
|
Rebamipide Rectal Enema Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 424
|
Sotalol 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 425
|
Sulfadiazine 100-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 426
|
Ursodiol 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2011
Pg. 427
|
Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 308-315
|
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient
Bramwell Bethany
|
Jul/Aug 2011
Pg. 316-319
|
Anesthetic Nasal Ointment
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 334
|
Citric Acid, Potassium Citrate, and Sodium Citrate Solution
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 335
|
Cromolyn Sodium 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 336
|
Glycopyrrolate 0.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 337
|
Hydrocortisone 100-mg/60-mL Retention Enema
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 338
|
Magnesium Sulfate Paste
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 339
|
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 342
|
Riboflavin 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 343
|
Preparation and Characterization of a New Alternative Formulation of Sodium p-aminosalicylate
Hergert Lisandro Y, Sperandeo Norma R, Allemandi Daniel A, Mazzieri Maria R
|
Jul/Aug 2011
Pg. 344-349
|
Treating Inner Ear Disorders with Intratympanic Drug Administration
McElhiney Linda F
|
Jul/Aug 2011
Pg. 302-307
|
Methylprednisolone 4-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 340
|
Oxandrolone 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2011
Pg. 341
|
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
McElhiney Linda F
|
May/Jun 2011
Pg. 194-199
|
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Wynn Tom, Goetsch Daniel
|
May/Jun 2011
Pg. 200-203
|
Treatment Options for Psoriasis
Williams LaVonn A, Humphreys Erica
|
May/Jun 2011
Pg. 204-213
|
Case Report: The Use of Compounded Metronidazole to Treat Clostridial and Campylobacterial Enteritis in an English Bulldog Puppy
Fellman Claire, Ray Jody, Jordan Dinah G, Hreish Viola
|
May/Jun 2011
Pg. 214-217
|
Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 242
|
Diclofenac Sodium 1% Topical Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 243
|
Ibuprofen 5% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 244
|
Melatonin 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2011
Pg. 246
|
Sport Body Cooler
Allen Loyd V Jr
|
May/Jun 2011
Pg. 247
|
Tannic Acid 5% Alcohol Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 248
|
Triamcinolone 0.1% Lotion
Allen Loyd V Jr
|
May/Jun 2011
Pg. 249
|
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Allen Loyd V Jr
|
May/Jun 2011
Pg. 245
|
Triclosan 2% Topical Cream
Allen Loyd V Jr
|
May/Jun 2011
Pg. 250
|
Wound Cleaner Solution
Allen Loyd V Jr
|
May/Jun 2011
Pg. 251
|
Testosterone Levels in an Aging Population: Screen, Measure, and Restore
Kells John, DollbaumCharles M
|
Mar/Apr 2011
Pg. 102-112
|
Case Report: Clindamycin Hydrochloride 1% Otic Suspension in the Management of Otitis Externa in a Canine
Rudner Shara, Pora Amanda, DeMeo Jennifer
|
Mar/Apr 2011
Pg. 114-116
|
The Relevance of the Soviet Pharmaceutical Industry and Dispensing: Dependence on Traditional Compounding
Conroy Mary Schaeffer
|
Mar/Apr 2011
Pg. 117-122
|
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease
Corsini Lindsay, Williams LaVonn A
|
Mar/Apr 2011
Pg. 124-128
|
Acetylcysteine 1% or 10% Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 156
|
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 157
|
Clopidogrel 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 158
|
Dextromethorphan Hydrobromide 15-mg Oral Film Strip
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 159
|
Hank's Balanced Salt Solution (Stock Solution)
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 160
|
Levamisole 25-mg/mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 161
|
Mandl's Paint
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 162
|
Massage Rub, Oil Free
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 163
|
Oral Film Strip Vehicle
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 164
|
Tea Tree Oil Acne Gel
Allen Loyd V Jr
|
Mar/Apr 2011
Pg. 165
|
Goliath: Case Report on a Canine Case of Epilepsy
Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
|
Jan/Feb 2011
Pg. 27-31
|
Diclofenac Sodium 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 64
|
Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 65
|
Ibuprofen 5% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 66
|
Mandelic Acid 5% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 67
|
Methotrexate 30-mg/g Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 68
|
Piroxicam 1% Gel
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 69
|
Pramoxine 1% Cream
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 70
|
Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 71
|
Terbenafine Hydrochloride Bilayer Nail Lacquer
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 72
|
Vancomycin Hydrochloride 25-mg/mL Solution
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 73
|
All-Purpose Nipple Ointment: A Compounding Solution to Common Problems with Breastfeeding
Williams KaCee D
|
Nov/Dec 2010
Pg. 484-486
|
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Rudner Shara, Browne Paul
|
Nov/Dec 2010
Pg. 488-491
|
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 512
|
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 513
|
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 514
|
Capsaicin 0.05% Clear Medication Stick
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 517
|
Glutathione 25% in Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 518
|
Gramicidin 13% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 519
|
Ketoprofen 2% Oral Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 521
|
The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
|
Nov/Dec 2010
Pg. 465-471
|
"My Hip Hurts": A Collaboration of Clinicians in the Treatment of Adhesive Capsulitis to Optimize Patient Care
Cox Chris
|
Nov/Dec 2010
Pg. 480-483
|
Bromazepam 2.5-mg/mL Drops
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 515
|
Bromhexine Hydrochloride 0.8-mg/mL Syrup
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 516
|
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel
Allen Loyd V Jr
|
Nov/Dec 2010
Pg. 520
|
Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date
Pignato Alyssa, Pankaskie Marvin, Birnie Christine
|
Nov/Dec 2010
Pg. 522-525
|
Tetracaine Lollipops for the Suppression of Extreme Gag Reflex in Dental Patients
Muller George, Case Tyler, Deen Griffin L
|
Sep/Oct 2010
Pg. 395-399
|
Alpha-Bisabolol Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 420
|
Icy Blue Camphorated Gel
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 422
|
Carvedilol 1-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 423
|
Buspirone 2.5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 424
|
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A, Llabrés M, Fariña JB
|
Sep/Oct 2010
Pg. 430-435
|
Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 421
|
Triclosan 0.28% Mouthwash
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 425
|
Rufinamide 40-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 426
|
Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 427
|
Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 428
|
Polidocanol 0.5% Wound Spray
Allen Loyd V Jr
|
Sep/Oct 2010
Pg. 429
|
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together
McElhiney Linda F
|
Jul/Aug 2010
Pg. 270-274
|
Considerations for Percutaneous Absorption
Newton Stephen J, Cook Jennifer M
|
Jul/Aug 2010
Pg. 301-304
|
Acyclovir with Benzocaine Lip Balm
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 332
|
Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 333
|
Amitriptyline Hydrochloride Suppositories
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 334
|
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel, White Lyndell
|
Jul/Aug 2010
Pg. 310-314
|
Ampicillin 250-mg Suppository
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 335
|
Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 336
|
Buprenorphine Hydrochloride Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 337
|
Chloroprocaine Hydrochloride Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 338
|
Cyanocobalamin, Choline, and Niacinamide Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 339
|
Fenoldopam Mesylate Injection
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 340
|
Flurbiprofen 5% Bioadhesive Gel for Gingivitis
Allen Loyd V Jr
|
Jul/Aug 2010
Pg. 341
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
Managing Pain with Transdermal Ketoprofen
Williams KaCee D
|
May/Jun 2010
Pg. 204-206
|
Potential Treatments for Radiation Dermatitis
Corsini Lindsay
|
May/Jun 2010
Pg. 210-213
|
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report
Muller George
|
May/Jun 2010
Pg. 215-217
|
Bacitracin 10,000-Units/mL Ophthalmic Solution
Allen Loyd V Jr
|
May/Jun 2010
Pg. 240
|
Carprofen 2.5-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 241
|
Celecoxib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 242
|
The Role of Sex Hormones on Fibromyalgia Pain Mediators
Bramwell Bethany L
|
May/Jun 2010
Pg. 193-199
|
Clozapine 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 243
|
Cohen's Rectal Ointment
Allen Loyd V Jr
|
May/Jun 2010
Pg. 244
|
Cyclophosphamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 245
|
Lansoprazole 3-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 246
|
Rifaximin 20-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 247
|
Sunitinib 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2010
Pg. 248
|
Voriconazole 40-mg/mL Oral Suspension, Veterinary
Allen Loyd V Jr
|
May/Jun 2010
Pg. 249
|
Compounding Rifampin Suspensions with Improved Injectability for Nasogastric Enteral Feeding Tube Administration
de Villiers Melgardt M, Vogel Laura, Bogenschutz Monica C, Fingerhut Bonnie J, D'Silva Joseph B, Moore Anne
|
May/Jun 2010
Pg. 250-256
|
Emerging Evidence for Androgen Replacement Therapy in Aging Men
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 94-99
|
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Bramwell Bethany L
|
Mar/Apr 2010
Pg. 108-111
|
Case Report: The Use of Inhaled Cyclosporine to Treat Bronchiolitis Obliterans Syndrome in a Lung Transplant Patient
McElhiney Linda F
|
Mar/Apr 2010
Pg. 112-115
|
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
McElhiney Linda F
|
Mar/Apr 2010
Pg. 118-123
|
Acyclovir 5% in Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 150
|
Acyclovir 200-mg/5-mL Oral Suspension (From the Injection)
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 151
|
Ciclopirox 10% in Isopropyl Alcohol Nail Solution
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 152
|
Clotrimazole 1% Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 153
|
Cyclosporin 10-mg/g in Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 154
|
Dexpanthenol 5% Gel-Cream
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 155
|
Lamotrigine 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 156
|
Metolazone 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 157
|
Plasticized Hydrocarbon Gel
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 158
|
Oral Adhesive Paste
Allen Loyd V Jr
|
Mar/Apr 2010
Pg. 159
|
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis
Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
|
Jan/Feb 2010
Pg. 40-45
|
Ketoprofen 100-mg/5-mL Mouth Rinse
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 68
|
Metronidazole in Normal Saline Enema
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 69
|
Ophthalmic Toning-Lubricating Drops
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 70
|
Solprotex 2.5% Lotion
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 71
|
Testosterone 1% in Alcoholic Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 72
|
Tetracaine 4% and Menthol 5% Topical Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 73
|
Trigger Point Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 75
|
Sleepless in America: Compounding with Melatonin
Wynn Tom, Rawlings Kate
|
Jan/Feb 2010
Pg. 10-13
|
Compounding Pharmacy: A Unique Service for a Unique Population
Williams LaVonn A, Franck Paul
|
Jan/Feb 2010
Pg. 19-20
|
Hand Sanitizer Gel
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 66
|
Hydrocarbon-Free Lotion
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 67
|
Tobramycin Sulfate 0.3% and Diclofenac Sodium 0.1% Ophthalmic Solution
Allen Loyd V Jr
|
Jan/Feb 2010
Pg. 74
|
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms
Bramwell Bethany L
|
Nov/Dec 2009
Pg. 498-505
|
Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis
Mixon William, Angelle Patricea (Patsy), Chang Richard I
|
Nov/Dec 2009
Pg. 506-515
|
Cidofovir 0.2-mg/mL Intravitreous Injection
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 554
|
Fluconazole 2% Topical Microemulsion
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 555
|
Gentian Violet Vaginal Suppositories
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 556
|
Ichthammol 10% Otic Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 557
|
The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel
Arnold John J, Asbill Scott
|
Nov/Dec 2009
Pg. 569-571
|
Lubow's Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 558
|
Miconazole 1% Ophthalmic Solution, Veterinary
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 559
|
Topiramate 6-mg/mL Oral Suspension
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 560
|
Twevan Cream
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 561
|
Voriconazole 2% Ophthalmic Solution
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 562
|
Wound Gel
Allen Loyd V Jr
|
Nov/Dec 2009
Pg. 563
|
Transdermal Dosing Considerations for Veterinarians
Williams KaCee D
|
Sep/Oct 2009
Pg. 358-360
|
Little Thief: The Domestic Ferret
Benischek Rita L
|
Sep/Oct 2009
Pg. 362-365
|
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Williams LaVonn A, Riley Kari
|
Sep/Oct 2009
Pg. 367-371
|
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Williams LaVonn A, Fokken Dawn
|
Sep/Oct 2009
Pg. 386-389
|
Aceclofenac 1.5% Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 428
|
Amlodipine Besylate 1 mg/mL Veterinary Suspension
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 429
|
Cooling Ointment
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 430
|
Emanuel Butt Paste
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 431
|
Ferric Pyrophosphate 50-mg/mL Solution for Iontophoresis
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 432
|
Azithromycin in the Treatment of Pneumonic Foals
Bramwell Bethany L, Williams LaVonn A
|
Sep/Oct 2009
Pg. 382-384
|
Lidocaine 10% Oral Pluronic Lecithin Organogel
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 433
|
Mechlorethamine Hydrochloride 0.02% Topical
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 434
|
Myristyl Nicotinate 5% Topical Gel
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 435
|
Nitroglycerin 4-mg Suppository
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 436
|
Zonisamide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Sep/Oct 2009
Pg. 437
|
Return to Top |